Following symptoms of those patients with weak stomach, loss of appetite and full stomach pit, and those who are easily fatigued, anemic and likely to have cold limbs: Gastritis, gastric atony, gastroptosis, maldigestion, anorexia, gastric pain, vomiting.
Conditions
Interventions
investigational material(s)
Generic name etc : Rikkunshito
INN of investigational material : -
Therapeutic category code : 52- Chinese medicines
Dosage and Administration for Investigational material
Sponsors
Tsumura & Co.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: TJ-43 is indicated for the relief of the following symptoms of those patients with weak stomach, loss of appetite and full stomach pit, and those who are easily fatigued, anemic and likely to have cold limbs: Gastritis, gastric atony, gastroptosis, maldigestion, anorexia, gastric pain, vomiting. The usual adult dose is 7.5 g/day orally in 2 or 3 divided doses before or between meals. Patients who have never taken TJ-43 in the past, or have been 6 months or more since the last dose.
Exclusion criteria
Exclusion criteria: -
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| safety Presence or absence of adverse event, adverse event name, onset date, severity, treatment of TJ-43, outcome and outcome date, causal relationship with TJ-43, treatment details for adverse event. | — |
Secondary
| Measure | Time frame |
|---|---|
| efficacy other Effectiveness; improvement, no change, worse, undecidable Treatment satisfaction: fully satisfactory treatment, almost satisfactory treatment, unsatisfied treatment only, treatment not being carried out, undecidable | — |
Countries
Japan
Outcome results
None listed